Literature DB >> 17145094

Ethnic differences in frequencies of gene polymorphisms in the MYCL1 region and modulation of lung cancer patients' survival.

Monica Spinola1, F Stefania Falvella, Antonella Galvan, Carmen Pignatiello, Vera P Leoni, Ugo Pastorino, Rita Paroni, Shuqing Chen, Vidar Skaug, Aage Haugen, Tommaso A Dragani.   

Abstract

Linkage disequilibrium (LD) analysis to refine a region associated with lung cancer progression on chromosome 1p34 identified a 106 kb LD block that includes MYCL1, TRIT1 (tRNA isopentenyltransferase 1) and MFSD2 (major facilitator superfamily domain-containing 2). Case-only association study on SNPs mapping in TRIT1 and MFSD2 indicated that the rare Leu allele (frequency: 0.04) of the TRIT1 Phe202Leu variation predicts short survival as compared to the common Phe/Phe genotype (hazard ratio (HR)=1.7; 95% CI, 1.03-2.86; P=0.039) in 335 Italian lung adenocarcinoma samples. A replication study in an independent population of 246 Norwegian lung cancer patients confirmed the significant association of the Phe202Leu polymorphism with patients' survival, but the rare allele was associated with better survival rate (HR=0.5; 95% CI, 0.26-0.91; P=0.023). The rare allele of TRIT1 Phe202Leu SNP was approximately seven-fold more frequent in Asian than in Caucasian subjects and three additional SNPs in the TRIT1 and MFSD2 genes showed ethnic differences in allelic frequencies. These results suggest that polymorphisms in the MYCL1 LD region affect lung cancer survival but that the functional element(s) may show population-specific patterns.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145094     DOI: 10.1016/j.lungcan.2006.10.023

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

1.  Human cells have a limited set of tRNA anticodon loop substrates of the tRNA isopentenyltransferase TRIT1 tumor suppressor.

Authors:  Tek N Lamichhane; Sandy Mattijssen; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2013-10-14       Impact factor: 4.272

2.  An In Vitro Assay to Detect tRNA-Isopentenyl Transferase Activity.

Authors:  Antonio E Chambers; Adam E Richardson; David F Read; Thomas J Waller; Douglas A Bernstein; Philip J Smaldino
Journal:  J Vis Exp       Date:  2018-10-08       Impact factor: 1.355

3.  MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachment.

Authors:  Monica Spinola; Felicia S Falvella; Francesca Colombo; James P Sullivan; David S Shames; Luc Girard; Paola Spessotto; John D Minna; Tommaso A Dragani
Journal:  Mol Cancer       Date:  2010-03-17       Impact factor: 27.401

4.  A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A.

Authors:  Francesca Colombo; Felicia S Falvella; Antonella Galvan; Elisa Frullanti; Hideo Kunitoh; Toshikazu Ushijima; Tommaso A Dragani
Journal:  Mol Cancer       Date:  2011-07-07       Impact factor: 27.401

Review 5.  Impact of genetic notification on smoking cessation: systematic review and pooled-analysis.

Authors:  Sylviane de Viron; Johan Van der Heyden; Elena Ambrosino; Marc Arbyn; Angela Brand; Herman Van Oyen
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

6.  Defective i6A37 modification of mitochondrial and cytosolic tRNAs results from pathogenic mutations in TRIT1 and its substrate tRNA.

Authors:  John W Yarham; Tek N Lamichhane; Angela Pyle; Sandy Mattijssen; Enrico Baruffini; Francesco Bruni; Claudia Donnini; Alex Vassilev; Langping He; Emma L Blakely; Helen Griffin; Mauro Santibanez-Koref; Laurence A Bindoff; Ileana Ferrero; Patrick F Chinnery; Robert McFarland; Richard J Maraia; Robert W Taylor
Journal:  PLoS Genet       Date:  2014-06-05       Impact factor: 5.917

7.  The i6A37 tRNA modification is essential for proper decoding of UUX-Leucine codons during rpoS and iraP translation.

Authors:  Joseph I Aubee; Morenike Olu; Karl M Thompson
Journal:  RNA       Date:  2016-03-15       Impact factor: 4.942

8.  Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL.

Authors:  Kazuhito Suzuki; Kouhei Yamamoto; Yasuhiro Arakawa; Hisashi Yamada; Keisuke Aiba; Masanobu Kitagawa
Journal:  Anticancer Drugs       Date:  2016-09       Impact factor: 2.248

9.  Targeting mitochondrial and cytosolic substrates of TRIT1 isopentenyltransferase: Specificity determinants and tRNA-i6A37 profiles.

Authors:  Abdul Khalique; Sandy Mattijssen; Alexander F Haddad; Shereen Chaudhry; Richard J Maraia
Journal:  PLoS Genet       Date:  2020-04-23       Impact factor: 5.917

Review 10.  Insights into major facilitator superfamily domain-containing protein-2a (Mfsd2a) in physiology and pathophysiology. What do we know so far?

Authors:  Pinar Eser Ocak; Umut Ocak; Prativa Sherchan; John H Zhang; Jiping Tang
Journal:  J Neurosci Res       Date:  2018-10-22       Impact factor: 4.164

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.